Multisubunit complex eEF1H in human glial tumors: From mRNA to protein

Biopolymers and Cell

Volumn 26, Issue 4, 2010, Pages 317-321

  Veremieva, M V ^a   Malysheva, T A ^b   Zozulya, Y P ^b   Rozumenko, V D ^b   Sidorik, L L ^a   Kavsan, V M ^a   Negrutskii, B S ^a   El'skaya A V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b Institute of Neurosurgery Ams of Ukraine   (Ukraine)

Author keywords

Human glial brain tumors; Translation elongation factor eEF1H

Indexed keywords

ELONGATION FACTOR; ELONGATION FACTOR 1A; ELONGATION FACTOR 1B ALPHA; ELONGATION FACTOR 1B BETA; ELONGATION FACTOR 1B GAMMA; MESSENGER RNA; POLYCLONAL ANTIBODY; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; PROTEIN CONTENT; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 77955605636     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.000166     Document Type: Article

References (16)

1. Negrutskii B. S., El’skaya A. V. Eukaryotic translation elon- gation factor 1a: structure, expression, functions, and pos-sible role in aminoacyl-tRNA channeling. Prog. Nucl. Acid Res. Mol. Biol. 1998. 60. P. 47-78.
2. IUMBMB. Prokaryotic and eukaryotic translation factors. Ad Hoc Nomenclature Subcommittee Report. Biochimie. 1996. 78, N 11-12. P. 1119-1122.
3. Joseph P., O’Kernick C., Othumpangat S., Lei Y., Yuan B., Ong T. Expression profile of eukaryotic translation factors in human cancer tissues and cell lines. Mol. Carcinogen. 2004. 40, N 3. P. 171-179.
4. Ogawa K., Utsunomiya T., Mimori K., Tanaka Y., Inoue H., Murayama S., Mori M. Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma. Br. J. Cancer. 2004. 91, N 2. P. 282-286.
5. Ender B., Lynch P., Kim Y. H., Inamdar N. Y., Cleary K. R., Frazier M. L. Overexpression of an elongation factor-1 gam-ma-hybridizing RNA in colorectal adenomas. Mol. Carcino- gen. 1993. 7, N 1. P. 18-20.
6. De Bortoli M., Castellino R. C., Lu X. Y., Deyo J., Sturla L. M., Adesina A. M., Perlaky L., Pomeroy S. L., Lau C. C., Man T. K., Rao P. H., Kim J. Y. Medulloblastoma outcome is ad- versely associated with overexpression of EEF1D, RPL30,and RPS20 on the long arm of chromosome 8. BMC Cancer. 2006. 6. P. 223.
7. Robert F., Carrier M., Rawe S., Chen S., Lowe S., Pelletier J. Altering chemosensitivity by modulating translation elonga-tion. PloS One. 2009. 4, N 5. e5428.
8. Veremieva M., Shostak K., Malysheva T., Zozulya Y., Rozu- menko V., Kavsan V., Negrutskii B. Expression of different subunits of eukaryotic translation elongation factor eEF1 in human glial brain tumors. Biopolym. cell. 2008. 24, N 4. P. 310-317.
9. Kleihues P., Cavenee W. K. World Health Organization clas- sification of tumors of the nervous system. Lyon: IARC/WHO, 2000.
10. Maier T., Guell M., Serrano L. Correlation of mRNA and pro- tein in complex biological samples. FEBS Lett. 2009. 583,N 24. P. 3966-3973.
11. Bradford M. A rapid and sensitive method for the quanti- tation of microgram quantities of protein utilizing the prin-ciple of protein-dye binding. Anal. Biochem. 1976. 72. P. 248-254.
12. Al-Maghrebi M., Anim J. T., Olalu A. A. Up-regulation of eu- karyotic elongation factor-1 subunits in breast carcinoma. Anticancer Res. 2005. 25. P. 2573-2578.
13. Chi K., Jones D., Frazier M. Expression of an elongation fac- tor 1 gamma-related sequence in adenocarcinomas of the co-lon. Gastroenterology. 1992. 103, N 1. P. 98-102.
14. Mimori K., Mori M., Tanaka S., Akiyoshi T., Sugimachi K. The overexpression of elongation factor 1 gamma mRNA in gastric carcinoma. Cancer. 1995. 75, N 6 (Suppl.). P. 1446-1449.
15. Lew Y., Jones D., Mars W., Evans D., Byrd D., Frazier M. Expression of elongation factor-1 gamma-related sequence in human pancreatic cancer. Pancreas. 1992. 7, N 2. P. 144- 152.
16. Olarewaju O., Ortiz P. A., Chowdhury W. Q., Chatterjee I., Kinzy T. G. The translation elongation factor eEF1B plays a role in the oxidative stress response pathway. RNA Biol. 2004. 1, N 2. P. 89-94.